Mucosal-associated invariant T (MAIT) cells produce inflammatory cytokines and cytotoxic granzymes in response to by-products of microbial riboflavin synthesis. Although MAIT cells are protective against some pathogens, we reasoned that they might contribute to pathology in chronic bacterial infection. We observed MAIT cells in proximity to Helicobacter pyloribacteria in human gastric tissue, and so, using MR1-tetramers, we examined whether MAIT cells contribute to chronic gastritis in a mouse H. pylori SS1 infection model. 
INTRODUCTION
Mucosal-associated invariant T (MAIT) cells are a subset of T cells, which are abundant in humans (1-8% in blood), but relatively rare (∼0.1% in blood) in specific pathogen-free (SPF)-housed laboratory mice (1) (2) (3) . MAIT cells typically express a semi-invariant αβ TCR, which in humans comprises TRAV1-TRAJ33 (Vα7.2-Jα33/20/12) TCR α-chain preferentially assembled with TRBV20 + (Vβ2) or TRBV6 + (Vβ13) TCR β-chains. In mice TRAV1-TRAJ33 (Vα19-Jα33) is mostly paired with TRBV19 (Vβ6) or TRBV13 (Vβ8) (3, 4) . MAIT TCRs are restricted by the monomorphic MHC-related protein 1 (MR1) (5) .
MR1 presents vitamin B-related Ags, including 5-(2-oxopropylideneamino)-6-D-
ribitylaminouracil (5-OP-RU) and 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil (5-OE-RU), which are derived from a precursor of microbial riboflavin (vitamin B2) biosynthesis and activate MAIT cells in vitro (6) (7) (8) . Indeed, a correlation between the presence of the riboflavin synthesis pathway in diverse microbes, including bacteria and yeast, with MAIT cell activation, led to the discovery of this pathway as furnishing this new class of Ag (6, 9) .
In contrast, microbes that do not synthesize riboflavin, such as Listeria monocytogenes
and Enterococcus faecalis, do not activate MAIT cells in a TCR-dependent manner (10) .
Thus, MAIT cells, which are enriched in tissues including lungs, intestine, and liver, are ideally placed to detect metabolically active microbes producing these Ags at mucosal sites.
MAIT cells have been shown to respond, in vivo, to bacteria that produce the riboflavinderived Ags, or to synthetic 5-OP-RU, in the presence of TLR agonists (1) .
MAIT cells rapidly secrete cytokines (including IFN-γ, IL-17, and TNF) upon stimulation and play a protective role in some model bacterial infections, including Klebsiella pneumoniae, Mycobacterium tuberculosis, M. bovis bacillus Calmette-Guérin, and Francisella tularensis (11) (12) (13) (14) . They can also be activated in a TCR-independent manner by cytokines or viral infections (15, 16) . Correlations between MAIT cell number and disease severity have been demonstrated for a range of chronic inflammatory conditions, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases, celiac disease, and ankylosing spondylitis (reviewed in Ref. 17) , suggesting that MAIT cells may also contribute to immunopathology. The basis of these correlative associations could involve MAIT cell activation, but might also be attributable to patient treatment (18) , which has not been considered in all studies. Few studies to date have attempted to understand the potential role of MAIT cells in immunopathology. Notably, Helicobacter pylori, which synthesizes riboflavin, and thus likely produces the known MAIT cell stimulatory Ags, has been shown to stimulate human MAIT cells in vitro (19) . Indeed, one study showed a reduction in MAIT cell numbers in H. pylori-infected patients' blood versus healthy controls, and human gastric MAIT cells can produce cytokines in response to H. pylori-infected macrophages in vitro (19) . Hence, we reasoned such a role might be demonstrated in unresolved (i.e., chronic) bacterial infection and tested this idea in a model of H. pylori gastritis.
H. pylori are Gram-negative extracellular bacteria that colonize the stomach. A large proportion of the world's population is infected with H. pylori and in most people, unless treated with antibiotics, the infection persists for decades. Most infected individuals remain asymptomatic, but 15-20% develop severe gastritis and overt disease such as peptic ulcers. A smaller proportion (1-3% of cases) develops gastric adenocarcinoma and fewer again (0.1%)
MALT lymphoma (20) . Infection with H. pylori induces both innate and adaptive immune responses by the host, generally Th1-biased, and tempered by regulatory T cells (reviewed in 
Compounds and immunogens
5-OP-RU was prepared as described previously (26 
Preparation of organs and isolation of cells
Single cell suspensions of lungs, blood, mesenteric lymph nodes, and spleen were prepared as described previously (1) . Gastric immune cells were isolated by perfusion from longitudinally halved stomachs, as described previously (32) .
Generation of MR1-tetramers
Mouse and human MR1-5-OP-RU labeled with BV421 or PE and MR1-6-FP (unlabeled) tetramers were generated as described previously (6) and prepared simultaneously. 4C ). Transcription factor staining was performed using a commercial transcription buffer staining set (eBioscience) according to the manufacturer's instructions.
Abs and flow cytometry

Assessment of gastritis
Longitudinally dissected half stomachs were fixed in 10% neutral buffered formalin, embedded in paraffin; 5-μm sections were stained with H&E and scored by a blinded operator under light microscopy. A pathologist also scored sections independently and the grading system is based on a previously described system (34) with modifications. Briefly, inflammation was assessed in two separate tissue sections for each animal using three parameters: 1) neutrophil infiltration and 2) lymphocyte infiltration: scored 0-4 on the basis of number of cells and whether widespread or multifocal infiltrate was observed, and 3) atrophy: scored 0-4 on the basis of loss of chief and parietal cells from the gastric glands.
PCR amplification and sequencing of TCRs
Single cells were sorted from S. Typhimurium BRD509-primed, H. pylori-infected C57BL/6 mouse stomachs on a FACSAria flow cytometer. PCR amplification and TCR sequencing was performed as previously described (3).
Statistical analysis
Statistical tests were performed using Prism software (version 6; GraphPad software, La Jolla, CA). Comparisons between groups were performed using one-way ANOVA, 
MAIT cells are present in the human gastric mucosa
Booth et al. (19) recently reported the presence of MAIT cells in human gastric biopsies detected with CD161 and TRAV1-2 markers. To confirm their observation, we examined stomach tissue obtained from patients following sleeve gastrectomy bariatric procedures by immunofluorescence microscopy. In three patients we observed CD3 + TRAV1-2 + cells within the gastric mucosa in close proximity to H. pylori ( Fig. 2A) . As we previously reported, a proportion of TRAV1-2 + cells are not MAIT cells, as judged by MR1-tetramer staining (3).
Thus, we examined single cell preparations by flow cytometry using MR1-tetramers. MAIT cells could be detected in single cell preparations of gastric tissue where they represented ∼1% (0.4-2.39) of T cells (Fig. 2B, 2C) . Costaining with TRAV1-2 Ab and MR1-tetramer confirmed that the majority of TRAV1-2 + CD161 + CD3 + cells were MAIT cells (Fig. 2D) .
Interestingly, there was a higher proportion of MR1-tetramer − ,TRAV1-2 + cells in the gastric tissue (∼25%), whereas in PBMCs almost all TRAV1-2 + cells were also MR1-tetramer + , thus highlighting the importance of defining MAIT cells using MR1-tetramers, particularly in studies involving cells isolated from tissues. Notably, there was a trend toward higher MAIT cell percentage in both PBMCs and gastric mucosae in patients where H. pylori were observed ( Fig. 2C) pylori SS1 infection (29) . MAIT cells are rare in naive, SPF-housed wt C57BL/6 mice compared with humans. In the stomach of naive mice they represent only ∼1% of αβ T lymphocytes and <∼100 MAIT cells are recovered from each stomach (Fig. 3A, 3B ). In mice, there are no MAIT cell-specific Abs and thus MR1-tetramers are necessary for MAIT cell detection. To determine if MAIT cells increase in number in response to H.
H. pylori infection in mice increases MAIT cell numbers in the stomach
pylori infection in vivo, we infected C57BL/6 mice with 10 7 CFU H. pylori SS1 orally, and examined the MAIT cells in stomachs by flow cytometry, with MR1-tetramers, 12 wk postinfection. To assess pathology, histological assessment by H&E staining was conducted.
Sections were scored blindly for cellular infiltration (neutrophilic and lymphocytic) and atrophy, a classical characteristic of chronic gastritis where there is a loss of chief and parietal cells, and a critical step in the development of gastric cancer (38 There was a significant increase in the number of MAIT cells, detected with MR1-tetramers, in the stomachs of infected mice compared with naive controls (Fig. 3A, 3B , left panel). An increase in non-MAIT αβ T cells was also observed in both infected wt mice and in MR1 −/− mice, which lack MAIT cells, compared with uninfected mice (Fig. 3B, right panel) .
Although no significant differences in absolute T cell numbers or gastric pathology scores (Fig. 3D) were observed between wt and MR1 −/− mice (Fig. 3B, 3C) , the absolute number of MAIT cells, but not non-MAIT αβ T cells, correlated with an increase in gastric atrophy at 12 wk postinfection (Fig. 3C) , suggesting a role for MAIT cells in driving pathology during chronic H. pylori infection.
An increase in gastric MAIT cells upon H. pylori infection of Vα19iCα−/−MR1+ mice is associated with severe pathology
Given the low numbers of T cells that can be isolated from naive stomachs, the analysis of Fig. 4A-C) . MR1-tetramers are highly specific for MAIT cells, but in Vα19iCα −/− mice, where the TCR repertoire is abnormally skewed toward selection of the MAIT Vα, a small proportion of "MAIT-like" cells also bind. These are thought to be MHCrestricted (14) . A small population of these cells was noted in Vα19iCα −/− MR1 −/− mice ( Fig.   4A-C) (Fig. 4A, 4D) , consistent with the increase in MAIT cells identified by tetramer staining (Fig. 4B, 4C ( Fig. 3A, 3B ), compared with ∼1-3% in the human gastric mucosa (19) (Fig. 2B) . We BRD509 and after 6-10 wk, when the Salmonella bacteria are cleared to below detectable levels, mice were challenged by gastric infection with H. pylori SS1 (Fig. 5A) . As expected, prior pulmonary infection with Salmonella not only expanded the proportion of MAIT cells in the lungs and blood of infected mice, but also in the stomachs (Fig. 5B) . Notably, in the stomach, the proportion of MAIT cells increased to ∼6% of T cells (Fig. 5B) . When preprimed mice were subsequently challenged with H. pylori, there was an increase in MAIT cell numbers as early as 2 wk postinfection with a significant increase over time (Fig. 5C 
Stomach MAIT cells induced following H. pylori infection exhibit a Tc17/Tc1 profile
We next examined the phenotype of the MAIT cells accumulating after H. pylori infection in mice that were preboosted with S. Typhimurium. MAIT cells isolated from both the lungs and the stomach retained an "effector memory" phenotype, as previously described (1, 24), being CD44 + and CD62L lo (Fig. 6A) . The majority of gastric MAIT cells expressed CD69
and CD103, consistent with a tissue-resident phenotype (19) (Fig. 6B) ; this was also true for non-MAIT αβ T cells accumulating in the stomach after 8 wk of infection with H.
pylori. There was a preferential accumulation of CD8 + MAIT cells in the stomach (Fig. 6C) and multiplex PCR and sequencing of single cells showed a TCR repertoire consistent with MAIT cells ( (Fig. 7) . T-bet was expressed on almost all MAIT cells after H. pylori infection (87-98% in primed and H. pylori-infected, and 91-93% in H.
pylori only) (Fig. 7) , and the small number of cells lacking T-bet were either RORγt and PLZF positive or negative. Thus, MAIT cells accumulating in the stomach after H.
pylori infection have a transcription factor profile consistent with Tc17/Tc1-type cells characteristic of proinflammatory capability.
MAIT cells are important for early recruitment of other T cells
In order to understand the implications of MAIT cell accumulation during gastric infection, we examined the effect of MAIT cell induction on the non-MAIT αβ T cell response. In (Fig. 8A ). An important consideration is that, in addition to MAIT cell activation, Salmonella infection is expected to prime a complex immune response. To address this, we infected mice with a mutant strain of S. Typhimurium BRD509 in which key genes involved in riboflavin synthesis, ribD and ribH, are deleted (Salm.ΔribDH) (1). These mice did not accumulate MAIT cells in their stomachs following subsequent H. pylori infection (Fig. 8B) . However, the response could be rescued when BRD509ΔribDH was supplemented with synthetic 5-OP-RU Ag (Fig. 8B) . This is consistent with our previous studies, which showed that MAIT cell responses are dependent on microbial riboflavin metabolites (1, 6, 9) . The non-MAIT αβ T cell accumulation was also partially dependent on the presence of 5-OP-RU, supplied either by the riboflavin producing S. Typhimurium BRD509 bacteria or by adding exogenous synthetic ligand (Fig. 8C) , suggesting a role of MAIT cells for recruiting other T cells.
Similar to our previous observations in the lung model (1), this result could be reproduced by intranasal introduction of the specific MAIT cell Ag 5-OP-RU and a costimulus such as the TLR2/6 agonist S- [2,3-bis(palmitoyloxy) propyl] cysteine (Pam2Cys) (40) . In contrast, MAIT and non-MAIT αβ T cell accumulation was much less apparent when Pam2Cys was combined intranasally with the MR1 ligand 6-formyl pterin (6-FP, a folate metabolite), which does not stimulate MAIT cells (9) (Fig. 8D, 8E) . (Fig. 8) accumulation, an increase in other immune cells including neutrophils, macrophages, eosinophils, and dendritic cells (Fig. 9A-D) . This increase was significantly higher than in similarly primed and infected MR1 −/− mice, indicating a role for MAIT cells in the recruitment of other cell types. The MAIT cell accumulation and recruitment of other cell types was associated with gastritis, which was evident on H&E-stained stomach sections (Fig. 9E) , and in significantly increased pathology scores in wt mice, compared with MR1 −/− mice, for lymphocytic infiltrate and atrophy. Strikingly, all MAIT preboosted wt mice infected with H. pylori developed atrophic gastritis by 8 wk postinfection (Fig. 9F) ;
comparatively, only 2 of 5 MR1 −/− mice developed atrophic gastritis (score 1 out of 4).
Gastritis was also observed following H. pylori infection in wt mice primed with riboflavindeficient S. Typhimurium (Salm.ΔribDH) or with Pam2Cys, but this was significantly increased when the specific MAIT Ag 5-OP-RU was also added (Fig. 10) , further demonstrating that MR1-Ag dependent MAIT cell activation drives gastric pathology. Table 1 
